Royal Bank of Canada’s Urovant Sciences Ltd. UROV Stock Holding History

Royal Bank of Canada’s Portfolio UROV Stock Details UROV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-306	Closed	-$5K	–	7908
2020 Q4	$5K	Hold	306	–	–	﹤0.01%	6706
2020 Q3	$3K	Sell	306 -24	-7%	-$213	﹤0.01%	6278
2020 Q2	$3K	Sell	330 -8,975	-96%	-$86.1K	﹤0.01%	6238
2020 Q1	$86K	Buy	9,305 +9,000	+2,951%	+$108K	﹤0.01%	4868
2019 Q4	$5K	Hold	305	–	–	﹤0.01%	6388
2019 Q3	$3K	Hold	305	–	–	﹤0.01%	6245
2019 Q2	$2K	Buy	+305	New	+$2.5K	﹤0.01%	6639

Royal Bank of Canada's UROV Position: Q1 2021 in Review

Royal Bank of Canada sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 306 shares — an estimated $5K sold.

Royal Bank of Canada first reported a position in UROV in Q2 2019 and held it in 7 quarters. The position peaked at $86K in Q1 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

Royal Bank of Canada reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
Royal Bank of Canada sold 306 Urovant Sciences Ltd. shares in Q1 2021, an estimated $5K.
Royal Bank of Canada first reported a position in Urovant Sciences Ltd. in Q2 2019 and held it in 7 quarters.
Royal Bank of Canada's Urovant Sciences Ltd. position peaked at $86K in Q1 2020.
0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on Royal Bank of Canada's 13F filing for Q1 2021, filed 17 May 2021.